Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
20,14 USD | +2,86% |
|
0,00% | +11,95% |
Attività
Numero di dipendenti: 284
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Chemically Synthesized Medicines
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +86,52% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +86,52% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Kevin Lee
CEO | Chief Executive Officer | 55 | 01/09/15 |
Alethia Young
DFI | Director of Finance/CFO | 45 | 17/07/23 |
Alistair Milnes
COO | Chief Operating Officer | 51 | 01/01/21 |
Michael Skynner
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/16 |
Nicholas Keen
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/17 |
Travis Thompson
AUD | Comptroller/Controller/Auditor | - | 01/04/18 |
Jennifer Perry
PRN | Corporate Officer/Principal | - | - |
Zafar Qadir
LAW | General Counsel | - | 23/04/20 |
Santiago Arroyo
PRN | Corporate Officer/Principal | 64 | 31/03/23 |
Nigel Crockett
PRN | Corporate Officer/Principal | 59 | 29/10/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Pierre Legault
CHM | Chairman | 63 | 18/03/19 |
Director/Board Member | 61 | 17/03/21 | |
Richard Kender
BRD | Director/Board Member | 68 | 24/07/19 |
Janice Bourque
BRD | Director/Board Member | 67 | 18/07/19 |
Gregory Winter
FOU | Founder | 73 | 01/01/09 |
Kevin Lee
CEO | Chief Executive Officer | 55 | 01/09/15 |
Stephen Sands
BRD | Director/Board Member | 67 | 20/02 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 38 073 148 | 4 333 333 ( 11,38 %) | 0 | 11,38 % |
Coordinate società
Bicycle Therapeutics Plc
Granta Park Great Abington Portway Building
CB21 6GS, Cambridge
+44 1223 261 503
http://bicycletherapeutics.com![Indirizzo Bicycle Therapeutics plc(BCYC)](https://cdn.zonebourse.com/static/address/58740263.png)
Settore
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+11,95% | 1,35 Mrd | |
+16,57% | 121 Mrd | |
+17,85% | 110 Mrd | |
+17,15% | 25,98 Mrd | |
-24,18% | 19,27 Mrd | |
-18,56% | 15,99 Mrd | |
-18,02% | 15,66 Mrd | |
-47,75% | 14,5 Mrd | |
+57,18% | 14,47 Mrd | |
+5,15% | 13,91 Mrd |
- Borsa valori
- Azioni
- Azione BCYC
- Società Bicycle Therapeutics plc